Thirteen newly isolated monoclonal antibodies (MAbs) were used to study relationships between reovirus outer capsid proteins fr3, ,ulc, and X2 (core spike) and the cell attachment protein fr1. We focused on al-associated properties of serotype specificity and hemagglutination (HA). Competition between MAbs revealed two surface epitopes on I,lc that were highly conserved between reovirus serotype 1 Lang (T1L) and serotype 3 Dearing (T3D). There were several differences between TlL and T3D c3 epitope maps. Studies using TlL x T3D reassortants showed that primary sequence differences between TlL and T3D ff3 proteins accounted for differences in a3 epitope maps. Four of 12 non-ffl MAbs showed a serotype-associated pattern of binding to 25 reovirus field isolates. Thus, for reovirus field isolates, different ff1 proteins are associated with preferred epitopes on other outer capsid proteins. Further evidence for a close structural and functional interrelationship between ff3/Ilc and ff1 included (i) inhibition by f3 and ,ulc MAbs of frl-mediated HA, (ii) enhancement of ffl-mediated HA by proteolytic cleavage of ff3 and ,ulc, and (iii) genetic studies demonstrating that ffl controlled the capacity of f3 MAbs to inhibit HA. These data suggest that (i) epitopes on fr3 and ,ulc lie in close proximity to ff1 and that MAbs to these epitopes can modulate ffl-mediated functions, (ii) these spatial relationships have functional significance, since removal of ff3 and/or cleavage of ,ulc to 8 can enhance ff1 function, (iii) in nature, the ff1 protein places selective constraints on the epitope structure of the other capsid proteins, and (iv) viral susceptibility to antibody action can be determined by genes other than that encoding an antibody's epitope.
We developed a new panel of monoclonal antibodies (MAbs) to analyze the reovirus outer capsid. Our goal is to understand the structural basis for dynamic changes in the reovirus outer capsid which play a role in reovirus infection (4, 6, 40) . In this report, we focus on relationships between capsid proteins cr3, P1, and X2 and two properties of the reovirus c1 protein (hemagglutination [HA] and serotype specificity).
Reoviruses have a segmented double-stranded RNA genome surrounded by a double protein shell (reviewed in reference 38). The cr3, plc, and crl proteins form the outer capsid, and the X2 protein extends from the core to the viral surface. crl is the cell attachment protein and hemagglutinin and contains serotype-specific determinants (25, 43, 45) . a1 interacts with sialic acid residues on nucleated cells and on erythrocyte (RBC) glycophorin molecules (19, (30) (31) (32) . Isolated crl mediates HA (26, 28, 48) . The crl protein is divided between a globular head and a fibrous tail (2, 3, 5, 14, 15, 28, 29) , with a region of the fibrous tail encompassing amino acids 198 to 204 playing a role in HA by serotype 3 reovirus field isolates (13) . MAbs and monospecific antisera to the X2 and cr3 proteins can inhibit HA (21) , presumably as a result storage, quantitation, and plaque assay have been previously described (39, 42) . Phenylmethylsulfony fluoride (0.25 mM), pepstatin-A (0.5 ,ug/ml), leupeptin (0.5 ,ug/ml), and aprotinin (1%, wt/vol) (all from Sigma, St. Louis, Mo.) were added to the homogenization buffer during viral purifications.
Preparation of viral cores and ISVPs. Cores were prepared from purified virus (1013 particles per ml) in dialysis buffer (DB; 150 mM NaCl, 15 mM MgCl2, 10 mM Tris, pH 7.4) by adding 200 ,g of tosyllysine chloromethyl ketone-treated alpha-chymotrypsin (CHT; Sigma) per ml and incubating the mixture for 2 to 3 h at 37°C. Cores were purified on CsCl (1.3 to 1.55 g/ml) gradients, using an SW 50.1 rotor (Beckman, Smith Kline, Westfield, Mass.) at 40,000 rpm for 3 h, and dialyzed against core buffer (1 M NaCl, 100 mM MgCl2, 25 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid [HEPES; pH 8.0]). Intermediate subviral particles (ISVPs) were prepared by using either 1013 particles of TlL per ml or 3 x 1012 particles of T3D per ml. CHT (200 ,g/ml) was added, and the mixture was incubated at 37°C for 20 min. The reaction was stopped by adding phenylmethylsulfonyl fluoride to a final concentration of 2.5 mM and placing the mixture on ice. The digest was centrifuged in a 1.22-to 1.45-g/ml CsCl gradient, using an SW 28.1 rotor at 25,000 rpm for 4 to 6 h. ISVPs were dialyzed against DB. For hybridoma screening, whole viral digests without further gradient purification were used. To assess purified MAbs, CsCl gradient-purified virus, cores, and ISVPs were used. Protein components of viral digests were confirmed by gel electrophoresis.
Mice, mouse immunizations, and hybridoma production. C3H/HeNCr, C3H/HeJCr, BALB/c AnNCr, and A/JCr mice were obtained from the National Cancer Institute (Frederick, Md.) and were maintained in an American Association for the Acreditation of Laboratory Animal Care-accredited biosafety level 2 animal facility in accordance with all applicable National Institutes of Health and university guidelines. Twelve-week-old (BALB/c AnNCr x A/JCr)Fl (CAF1) mice were immunized and boosted with T3D (50 to 100 pug in complete Freund's adjuvant) intraperitoneally. Immunized mice produced antibody recognizing both T3D and TlL (data not shown). Three days prior to hybridoma fusion, mice were injected intravenously with 100 pl of UV-inactivated TlL or 3HA1 viral top component. Virus was UV inactivated by using a Spectroline model ENF-26 UV lamp (100 ILW/cm2; Spectronics Corp., Westbury, N.Y.) at a distance of 11.25 cm for 2 h at room temperature. Spleen cells were harvested and fused to the P3Ag8.6.5.3 myeloma line by using polyethylene glycol.
Selection and subcloning of hybridomas. Hybridomas were passaged and subcloned in Iscove's modified Dulbecco's modified Eagle's medium (IMDME; GIBCO, Grand Island, N.Y.) containing 20% fetal calf serum (FCS), 1 mM L-glutamine, 1 U of penicillin per ml, and 1 ,ug of streptomycin per ml. Selection was carried out in completed IMDME supplemented with hypoxanthine (13.6 ,ug/ml), thymidine (3.88 ,ug/ml), and aminopterin (0.175 ,ug/ml). Twelve hundred wells were screened for binding to T1L, T3D, and TlL ISVPs by enzyme-linked immunosorbent assay (ELISA; see below) and then rescreened after a second passage using protein-A peroxidase (Zymed, San Francisco, Calif.) to detect immunoglobulin G (IgG) MAbs. Twelve stable hybridomas were obtained after double subcloning using softagar cloning or limiting dilution on thymocyte feeder cells (C3H/HeJCr or C3H/HeNCr). The 5C6 hybridoma was separately isolated in our laboratory (14a) .
MAb purffication and isotype analysis. MAbs were purified from tissue culture medium as described previously (42 (11) .
HA and HI. HA was assayed by using 2% bovine RBCs (b-RBC; Colorado Serum Co., Denver, Colo.) or human type A-RBCs (h-RBC) as previously described (13 (Fig. 1) . 5C6 specificity was defined by using T3D x TlL reassortant viruses (Fig. 2) . 5C6 bound reassortants containing the TlL S1 gene segment better than those containing the T3D S1 gene segment (Wilcoxon, P < 0.001). As (Fig. 4) determined by ELISA gene segment encoding a3 determined how well 4F2 (Fig. 6) dtermwell (Fig. 7) . As expected, strain-specific HI by crl MAb 5C6 mapped to the S1 gene segment (encoding cr1). Surprisingly, strain-specific HI differences of a3 MAbs also mapped to the Si gene segment. This was true even for MAb 4F2, which binds T3D cr3 better than TlL cr3, an avidity difference which mapped to the S4 gene segment (Fig. 6 ). Epitopes bound by MAbs which are HI in the presence of the T3D S1 gene segment (lOC1, lOG10, and 4F2) were spatially distinct from the epitope bound by 8F12, which was HI in the presence of the TlL S1 gene segment (Fig. 3) .
(iii) Effect of MAbs on SGLP binding. One possible mechanism for HI by non-crl MAbs is direct blockade of crl binding to its receptor (SGLP) on the RBC. We assessed this possibility by using an ELISA to measure binding of b-SGLP to reovirus. T3D bound b-SGLP better than b-ASGLP, confirming the importance of sialic acid residues for T3D binding (data not shown). Several cr3 MAbs, and one ,ulc MAb, significantly inhibited binding of b-SGLP to T3D (were GI; Fig. 8 CHT removes cr3 and cleaves Rlc to 8, generating ISVPs (7, 24) which are capable of HA (28a). We examined whether conversion to ISVPs altered HA efficiency ( Table 3 ) and found that T3D ISVPs were significantly better than intact T3D at HA. This was true regardless of whether ISVPs and virions were compared on the basis of OD260 or by normalization of the total amount of 8 (data not shown). Conversion of TlL to ISVPs resulted in minimal HA enhancement and did not result in TlL becoming HA for b-RBC (data not shown). The T3D a1, but not that of T1L, is sensitive to CHT digestion (49) , raising the possibility that cleavage of the T3D crl was responsible for HA enhancement. However, proteolytic enhancement of HA is observed with serotype 3 reoviruses whose crl protein is not cleaved by CHT (28b). Thus, other events involved in conversion of virions to ISVPs (loss of a3 and/or conversion of ,ulc to 5) are likely responsible for enhancement of cr1 function.
DISCUSSION
Using a new panel of anti-reovirus MAbs, we have (i) identified epitopes on reovirus capsid proteins, (ii) demonstrated that there are serotype-associated epitopes on ar3, ,lc, and X2, (iii) shown that both a3 and pLlc MAbs can inhibit crl-mediated properties, (iv) demonstrated that HA efficiency can be modulated by structural changes in capsid proteins other than crl, and (v) shown that viral susceptibility to antibody action can be determined by a gene which does not encode the antibody's epitope.
Epitopes on reovirus capsid proteins. There are at least two surface epitopes on pulc (Fig. 3) , each residing within the a fragment of pulc (amino acids 43 to 581 of p1). Three of 4 pulc MAbs bound equally to different reovirus serotypes, suggesting, in accord with sequence data and tryptic peptide analysis (18, 23, 41, 47) , that the epitope structure of pulc is highly conserved. The 1OF6 epitope had several unique properties, and appears to be located in close proximity to crl. 10F6 was HI and GI, and was the only pulc MAb to show serotype-associated binding ( Fig. 4 and 8 ; Table 2 ).
There were significant differences between TlL and T3D cr3 epitope maps (Fig. 3) . Two of seven cr3 MAbs (4F2 and 8F12) had distinct competition patterns on TlL and T3D (Fig. 3) , likely secondary to the fact that each bound T3D better than TlL. These binding differences were due to intrinsic differences between TlL and T3D cr3 proteins (Fig.   6 ). There are only 11 amino acid differences between the TlL and T3D a3 proteins (1, 20) . One or more of these must compose part of the 4F2 and 8F12 epitopes. The 4F2 and 8F12 epitopes are likely to be located in close structural proximity to al, since these MAbs are both HI and GI.
Serotype-associated patterns of MAb binding. cr1 is the most serotype-specific reovirus outer capsid protein (16, 17, 21, 43, 45) , reflecting the fact that cr1 varies the most between prototypic strains of all the reovirus structural proteins (10, 12, 17, 18, 46, 47) . As expected, the crl MAbs G5 (9) and 5C6 (Fig. 4) show serotype-specific patterns of binding. Monospecific antisera to non-cl proteins can bind more efficiently to one prototypic reovirus than another (strain-specific binding [16, 21] ). We now extend these observations by demonstrating that MAbs identify non-al epitopes that preferentially occur in a serotype-associated pattern (Fig. 4) . This binding pattern could be due to steric hindrance of MAb binding to non-cl proteins by crl (which defines serotype), or to intrinsic structural differences in non-cl proteins between serotypes. Since strain-specific binding of MAbs 4F2 and 8F12 is determined by intrinsic differences between the TlL and T3D cr3 proteins, some serotype-associated binding to non-cl proteins is explained by a preferential association between certain non-al epitopes and selected a1 molecules. Two mechanisms might explain why specific epitope sets are present on viruses of a given serotype (Fig. 9) . Both mechanisms propose that certain epitope sets confer a selective advantage on a virus in nature, and thus viruses expressing these epitope sets come to predominate in field isolates.
"Structurally constrained" epitope sets would result from protein-protein interactions which enhance viral stability and survival because the proteins fit together better in the assembled capsid (Fig. 9a) . Interserotype reassortants with all combinations of outer capsid proteins can be generated in vitro (Fig. 2, 6 , and 7), demonstrating that coassembly of capsid proteins from a virus of a given serotype is not an absolute constraint on viral survival. Structurally constrained epitope sets could predominate because natural selective pressures are more rigorous than those found in the laboratory. The capacity of reovirus outer capsid proteins to evolve in an interdependent manner is well illustrated by pseudorevertants of temperature-sensitive (ts) reoviruses. Reversion from the ts phenotype is frequently associated with mutation in a protein which interacts with the protein containing the ts mutation (pseudorevertant) rather than back-mutation of the original ts lesion (true reversion [27, 33, (6, 40) . Perhaps these events are critical because they result in enhanced crl function.
Genetic control of viral susceptibility to antibody action. Several cr3 MAbs showed strain-specific patterns of HI (Table 2 ; Fig. 7 ). The capacity of cr3 MAbs to mediate strain-specific HI was determined by the S1 gene segment (encoding c1) rather than the S4 gene segment encoding the MAb target protein c3 (Fig. 7) . This shows that a viral gene (S1) encoding a protein (crl) other than an antibody's target (cr3) can 
